Loading...
INDEX: NASDAQ
SYMBOL: VKTX
NAME: Viking Therapeutics Inc
UPVOTES: 22
DOWNVOTES: 22


Description

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. VK5211 is a non-steroidal selective androgen receptor modulator (SARM). Its second program is focused on the development of orally available small molecule thyroid hormone receptor beta agonists. Its two molecules are VK2809 and VK0214. VK2809 is an orally available, tissue and receptor-subtype selective agonist of the thyroid beta receptor that is entering Phase II development for the treatment of patients with hypercholesterolemia and fatty liver disease. It is developing VK0214 for the treatment of X-linked adrenoleukodystrophy (X-ALD). It has a pipeline with approximately three additional programs targeting metabolic diseases and anemia.

Read Full Descript at Reuters

VKTX Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
AMDA10
AREX10
LLNW10
ARRY10
A10
NUAN10
SEDG10
AND10
F10
AMRS10
Stock SymbolUp VotesDown VotesVote
TSLA337124
CBIS326146
AMD311241
DIS181112
AMZN173117
NVDA158103
KTOS14495
NFLX14098
NAT11676
MSRT143106
Stock SymbolUp VotesDown VotesVote
COF51
XRX51
NYSE:LMT73
NUAN30
AMFL41
AC42
AUMN31
UNXL31
LLNW31
KNSC31
Stock SymbolUp VotesDown VotesVote
COF179
PULM147
82
ABBV115
AUMN105
MIK94
MNGA83
DFS127
ASTI105
ENDRQ61
Stock SymbolUp VotesDown VotesVote
TSLA337124
CBIS326146
AMD311241
DIS181112
AMZN173117
NVDA158103
KTOS14495
NFLX14098
NAT11676
MSRT143106

Last 10 Stocks Voted On

Stock SymbolActionVote
APAFFDOWNVOTE
VKTXDOWNVOTE
DRYSDOWNVOTE
SEDGUPVOTE
AMDAUPVOTE
AGRXDOWNVOTE
ACOLDOWNVOTE
ANDUPVOTE
AREXUPVOTE
AIDOWNVOTE